LIVE

HCM

HUTCHMED (China) Limited

HCM

NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic·Mkt cap $1.9B

$11.41

▲ +5.84%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$9.77 - $19.50

P/E

—

Fwd P/E

30.57

Beta

0.37

Div Yield

0.00%

Avg Vol

43.1K

Shares Out

—

Mkt Cap

$1.9B

Price action

Price chart

Down 31.3% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

▲

Bull Case

No bull reasons captured for this rating yet.

▼

Bear Case

2 risks

  • Low volatility (beta 0.4).
  • Significant premium - growth priced in

Growth

Revenue decline expected

Value

Significant premium - growth priced in

Momentum

Falling

-30.1% over 3m

Quality

Thin

Below average quality

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Jun 4, 2026

“
LATEST RECAP

Earnings recap unavailable for this period.

EPS surprise · last 4Q

No quarterly earnings data on file.

Next: Jun 4, 2026

Wall Street consensus

1 analyst · 100% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

1

100%

Hold

0%

Sell

0%

Median Price Target

$13.60

▲ +19.2% vs $11.41

Low $13.60
Median $13.60
High $13.60

Latest: Morgan Stanley · $13.60 · May 28, 2026

1 analyst covering

View full analyst page →

vs Industry

How HCM stacks vs Drug Manufacturers - Specialty & Generic

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.

Related

Peers & themes

Peers

No peer data available.

Themes

No themes assigned.